Back to search

Netherlands· NL-86852358b1e4

Fluoxetine Prolepha 60 mg, harde capsules

A fluoxetine product containing fluoxetinehydrochloride, registered in Netherlands by Prolepha Research B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC N06AB03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFluoxetine Prolepha 60 mg, harde caps…ATCN06AB03REGISTER NO.NL-86852358b1e4PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fluoxetine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06AB03 (fluoxetine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Fluoxetine · ATC N06AB03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fluoxetine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.084 in United States to $1.04 in Switzerland — a ×12 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Fluoxetine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.04
  • IT Italy$0.25
  • ES Spain$0.10
  • US United States$0.084 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUOXETINEHYDROCHLORIDE
Manufacturer
Prolepha Research B.V.
Country
Netherlands (NL)
ATC code
N06AB03
ATC class
Fluoxetine
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132389

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

598 interactions on record for fluoxetine.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluoxetine · interactions on record

598 records

  • 64 severe
  • 287 moderate
  • 4 minor
  • 120 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

123 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluoxetine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluoxetine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Felicium, Fluctine
  • Belgium · Fluoxetin Ab, Fluoxetine Eg
  • Bulgaria · Бифлокс
  • Cyprus · Afeksin, Fluoxetine Aurobindo
  • Czechia · Deprex, Fluoxetin Pharmconsul
  • Germany · Fluoxetin 1 A Pharma, Fluoxetin Abz
  • Denmark · Fluoxetin ”mylan”, Fluoxetin Hexal
  • Estonia · Fluoxetine Vitabalans, Flux
  • Spain · Fluoxetina Almus, Fluoxetina Aurovitas
  • Finland · Fluoxetine Vitabalans, Seromex
  • France · Fluoxetine Accord, Fluoxetine Almus
  • United Kingdom (Northern Ireland) · Fluoxetine, Fluoxetine Accord-Uk
  • Greece · Dagrilan, Exostrept
  • Croatia · Portal
  • Hungary · Floxet, Fluoxetin Zentiva
  • Ireland · Fluoxetine Activase Pharmaceuticals, Fluoxetine Brillpharma (Ireland)
  • Iceland · Fluoxetin Viatris, Fluoxetin Wh
  • Italy · Fluoxeren, Fluoxetina Accord
  • Lithuania · Fluoxetine Vitabalans, Flux
  • Luxembourg · Fluoxetin Ratiopharm, Fluoxetine Eg
  • Latvia · Fluoxetine Vitabalans, Flux
  • Malta · Fluoxetine Accord Healthcare, Fluoxetine Activase Pharmaceuticals
  • Norway · Fluoxetin Ratiopharm, Fluoxetin Sandoz
  • Poland · Andepin, Bioxetin
  • Portugal · Digassim, Fluoxetina Alter
  • Romania · Fluoxetină Arena, Fluoxin
  • Sweden · Fluoxetin Orifarm, Fluoxetin Ratiopharm
  • Slovenia · Fluoksetin Vitabalans, Fodiss
  • Slovakia · Fluoxetine Vitabalans, Magrilan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/439932f0-ce6a-4195-834a-d9965daf2b47
GET /v1/drugs/439932f0-ce6a-4195-834a-d9965daf2b47?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132389_smpc.pdf",
  "strength": null,
  "atc_label": "Fluoxetine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132389",
  "excipients": [
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "PATENTBLAUW V (E 131)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD",
    "ZWARTE INKT"
  ],
  "substances": [
    "FLUOXETINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132389.pdf",
  "authorised_at": "2026/06/01",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132389",
  "additional_monitoring": "N"
}

See everything about fluoxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.